Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

House Democrats finally pass landmark drug pricing bill

House Democrats finally pass landmark drug pricing bill the average price levied in six index countries – including Australia, Canada, France, Germany, Japan and the UK.

The 2019 CPhI Pharma Index Report

The 2019 CPhI Pharma Index Report 2019 saw Japan (7.97) rise above Germany (7.85) into the number one spot for API manufacturing, thanks to a small yet significant 2.5% score increase from the previous ... Finished product manufacturing. Similarly to API manufacturing and Innovativeness,

Novartis highlights emerging assets and late-stage pipeline at R&D day

Novartis highlights emerging assets and late-stage pipeline at R&D day This means that Novartis has plans to make 80 significant submissions to regulators for drug approvals from 2020-2022 in the US, Europe, Japan and China.

Two new senior hires announced at Ashfield

Two new senior hires announced at Ashfield After spending time within the UK business at Ashfield, he relocated to the US in 2010, and after a successful period there went on to spend five years in Japan. ... While in Japan, he established and grew the Ashfield CMIC business into a market

Astellas makes gene therapy a core focus with $3bn Audentes buy

Astellas makes gene therapy a core focus with $3bn Audentes buy Last year, Astellas dipped its toe into the sector by licensing a preclinical-stage therapy for amyotrophic lateral sclerosis (ALS) from Japan’s Gene Therapy Research Institution.

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics